Neuronetics STIM 深 滬
等待開盤 08-10 09:30:00 美东时间
2.38
+0.130
+5.78%
華盛通- 最 高2.415
- 今 開2.28
- 成交量 101.60万股
- 最 低 2.26
- 昨 收 2.25
- 總市值 16.56万
- 52周最高 3.80
- 市盈率 靜 --
- 換手率 1460.06%
- 52周最低 0.80
- 委 比 -60.48%
- 總股本 6.96万
- 歷史最高 39.39
- 量 比 0.73
- 振 幅 6.89%
- 歷史最低 0.52
- 每 手 1
- 風險率 0.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Neuronetics and Jorey Chernett Announce Shared Vision
Neuronetics, Inc. and its second-largest shareholder, Jorey Chernett, have established a framework to align the company's Board of Directors, management, and Mr. Chernett. Chernett expresses confidence in the company's financial position and management's execution. He will have the opportunity to recommend a new Board member. The company's largest shareholder, Madryn Asset Management, reaffirms its belief in Neuronetics' long-term prospects. Neur...
08-03 12:00
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Neuronetics, Inc. announced inducement awards, including restricted stock units (RSUs), to five new non-executive employees. The awards, granted under the 2020 Inducement Incentive Plan, vest over three to four years contingent on continued employment. Phillip McDaniel received 18,000 and 12,000 RSUs, Nicolas Jackson 9,000, Martin Webb 22,500 and 15,000, William Peschel 2,400, and Alex Vargas 2,400. Neuronetics is a leader in interventional menta...
07-31 21:00
美股牛股 | AMC院线劲升26%，《奥德赛》创R级片最佳开画票房；IREN大涨19%
AMC院线劲升26%，Q2财报超预期；IREN大涨19%，斩获28亿美元重磅AI云合同；ACHR升19%，携手Anduril进军军工领域>>
07-21 18:51
美股大行评级 | 伯恩斯坦上调Robinhood目标价从130美元升至160美元；纽约梅隆银行、Datadog、五三银行、旅行者财产险集团获多家机构上调评级
今日重点评级关注：Needham：维持Immuneering"买入"评级，目标价从11美元升至18美元；富瑞：维持塞德斯医疗"买入"评级，目标价从90美元升至100美元
07-21 11:36
Neuronetics Announces New CFO Amid Leadership Transitions
An update from Neuronetics ( ($STIM) ) is now available. On July 20, 2026, Neur...
07-21 04:29
Neuronetics appoints new CFO
Neuronetics (STIM) appointed Nir Naor as chief financial officer, effective July 23, 2026. Naor brings more than 20 years of finance and life sciences experience, most recently serving as CFO of Axoge...
07-21 04:22
Neuronetics Appoints Nir Naor CFO, Effective July 23,
Neuronetics, Inc. (NASDAQ:STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that Nir Naor will be appointed Chief Financial Officer effective July 2...
07-21 04:05
Why Is Neuronetics Stock Soaring Monday?
BTIG initiated coverage of Neuronetics Inc. (NASDAQ:STIM) on Monday, noting that the company is entering a pivotal new phase as the psilocybin opportunity takes center stage. Following the analyst initiation, Neuronetics shares surged over 28% on Monday. Greenbrook Acquisition Reshaped Business The ...
07-21 02:21
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
Neuronetics, Inc. announced several leadership changes: Nir Naor will become Chief Financial Officer on July 23, 2026, with over 20 years of finance and life sciences experience. Cory Anderson was promoted to Executive Vice President and General Manager of Greenbrook effective July 1, 2026, while Andrew Macan will step down as Executive Vice President, Chief Legal Officer & Corporate Secretary on August 15, 2026. Naor, known for delivering profit...
07-20 20:05
BTIG Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5
BTIG analyst Sam Eiber initiates coverage on Neuronetics (NASDAQ:STIM) with a Buy rating and announces Price Target of $5.
07-20 18:10
